Extraordinary General Meeting to approve the Business Combination
Definitive Proxy Statement Relating to a Merger, Acquisition, or Disposition
Analyst Day and Investor Day Aug 19, 2021 10:00 am EDT
Video 1: Procaps Group - The Future of Innovation In Pharmaceutical Oral Delivery Systems
Video 2: Procaps Group - Innovation As a Differentiation in Technology, Products and Culture
Upcoming Event
Company Overview
Procaps Group has experience in the development of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. We have direct presence in 13 countries in Latin America and we have more than 5,000 collaborators working under a sustainable model.
We develop, manufacture, and market over-the-counter (OTC) and prescription drugs, nutritional supplements and high-potential clinical solutions.
Investor Contact Information
Company
Procaps Group
9 Rue de Bitbourg
L-1273 Luxembourg
Grand Duchy of Luxembourg
Investor Relations
Chris Tyson/Doug Hobbs
SPAC Alpha IR+
T: 949-491-8235
LATN@mzgroup.us
Procaps Group Company Contact
Maria Alejandra Molina
Legal Compliance Director
T: (57)(5) 3719162)
mamolina@procaps.com.co